Adrià Juanola, Ann Thu Ma, Koos de Wit, Kohilan Gananandan, Olivier Roux, Giacomo Zaccherini, César Jiménez, Marta Tonon, Cristina Solé, Clara Villaseca, Frank E Uschner, Isabel Graupera, Elisa Pose, Maria José Moreta, Daniela Campion, Ulrich Beuers, Rajeshawar P Mookerjee, Claire Francoz, Francois Durand, Victor Vargas, Salvatore Piano, Sonia Alonso, Jonel Trebicka, Wim Laleman, Sumeet K Asrani, German Soriano, Carlo Alessandria, Miquel Serra-Burriel, Manuel Morales-Ruiz, Ferran Torres, Andrew S Allegretti, Aleksander Krag, Paolo Caraceni, Hugh Watson, Juan G Abraldes, Elsa Solà, Patrick S Kamath, Ruben Hernaez, Pere Ginès
BACKGROUND: Patients with decompensated cirrhosis experience high mortality rates. Current prognostic scores, including the model for end-stage liver disease (MELD), may underperform in settings other than in those they were initially developed. Novel biomarkers have been proposed to improve prognostication accuracy and even to predict development of complications. METHODS: We performed a systematic review and meta-analysis on novel urine and blood biomarkers and their ability to predict 90-day mortality in patients with decompensated cirrhosis...
December 7, 2023: Gut